Last Price
269.86
Today's Change
-3.01 (1.10%)
Day's Change
269.20 - 272.44
Trading Volume
634,988
Market Cap
130 Billion
Shares Outstanding
484 Million
Avg Volume
617,859
Avg Price (50 Days)
278.77
Avg Price (200 Days)
289.75
PE Ratio
30.91
EPS
8.73
Earnings Announcement
11-Feb-2025
Previous Close
272.87
Open
269.20
Day's Range
269.2 - 272.44
Year Range
265.14 - 313.55
Trading Volume
634,988
1 Day Change
-1.10%
5 Day Change
-1.53%
1 Month Change
-6.41%
3 Month Change
-5.41%
6 Month Change
-11.66%
Ytd Change
-4.03%
1 Year Change
-10.98%
3 Year Change
5.01%
5 Year Change
-16.44%
10 Year Change
199.31%
Max Change
32544.22%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.